Suchergebnisse - "Santos de Oliveira, Maria Helena"

PubPharm (9)

1

Characterization of the significant decline in humoral immune response six months post-SARS-CoV-2 mRNA vaccination : A systematic review

enthalten in: Journal of medical virology | 2022

von Notarte, K. | Guerrero-Arguero, I. | Velasco, J. | +10

2

The Predictive Value of Serum ACE2 and TMPRSS2 Concentrations in Patients with COVID-19-A Prospective Pilot Study

enthalten in: Journal of personalized medicine | 2022

von Kassif Lerner, R. | Stein Yeshurun, M. | Hemi, R. | +9

3

Characterization of the significant decline in humoral immune response six months post‐SARS‐CoV‐2 mRNA vaccination : A systematic review

enthalten in: Journal of Medical Virology | 2022

von Notarte, K. | Guerrero‐Arguero, I. | Velasco, J. | +10

4

Ups and Downs of COVID-19 : Can We Predict the Future? Local Analysis with Google Trends for Forecasting the Burden of COVID-19 in Pakistan

enthalten in: EJIFCC | 2021

von Ahmed, S. | Abid, M. | Santos de Oliveira, M. | +5

5

Clinical Predictors of SARS-CoV-2 Testing Pressure on Clinical Laboratories : A Multinational Study Analyzing Google Trends and Over 100 Million Diagnostic Tests

enthalten in: Laboratory medicine | 2021

von Lippi, G. | Mattiuzzi, C. | Santos de Oliveira, M. | +1

6

Utility of Google Trends in anticipating COVID-19 outbreaks in Poland

enthalten in: Polish archives of internal medicine | 2021

von Henry, B. | Szergyuk, I. | Santos de Oliveira, M. | +3

CommentOn: Pol Arch Intern Med. 2020 Jun 25;130(6):478-480. - PMID 32588578

7

The anti-inflammatory cytokine response characterized by elevated interleukin-10 is a stronger predictor of severe disease and poor outcomes than the pro-inflammatory cytokine response in coronavirus disease 2019 (COVID-19)

enthalten in: Clinical chemistry and laboratory medicine | 2021

von Henry, B. | Benoit, S. | Vikse, J. | +7

8

The anti-inflammatory cytokine response characterized by elevated interleukin-10 is a stronger predictor of severe disease and poor outcomes than the pro-inflammatory cytokine response in coronavirus disease 2019 (COVID-19)

enthalten in: Clinical chemistry and laboratory medicine | 2020

von Henry, B. | Benoit, S. | Vikse, J. | +7

9

The anti-inflammatory cytokine response characterized by elevated interleukin-10 is a stronger predictor of severe disease and poor outcomes than the pro-inflammatory cytokine response in coronavirus disease 2019 (COVID-19)

enthalten in: Clinical chemistry and laboratory medicine | 2020

von Henry, B. | Benoit, S. | Vikse, J. | +7

1
[1]